BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 12963564)

  • 1. Thrombosis prophylaxis in patient populations with a central venous catheter: a systematic review.
    Klerk CP; Smorenburg SM; Büller HR
    Arch Intern Med; 2003 Sep; 163(16):1913-21. PubMed ID: 12963564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters.
    Akl EA; Karmath G; Yosuico V; Kim SY; Barba M; Sperati F; Cook D; Schünemann HJ
    Cochrane Database Syst Rev; 2007 Jul; (3):CD006468. PubMed ID: 17636845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic anticoagulant prophylaxis for central catheter-associated venous thrombosis in cancer patients.
    Chan A; Iannucci A; Dager WE
    Ann Pharmacother; 2007 Apr; 41(4):635-41. PubMed ID: 17355999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboprophylaxis in cancer patients with central venous catheters. A systematic review and meta-analysis.
    Chaukiyal P; Nautiyal A; Radhakrishnan S; Singh S; Navaneethan SD
    Thromb Haemost; 2008 Jan; 99(1):38-43. PubMed ID: 18217132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic complications of central venous catheters in cancer patients.
    Kuter DJ
    Oncologist; 2004; 9(2):207-16. PubMed ID: 15047925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylaxis of catheter-related deep vein thrombosis in cancer patients with low-dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study.
    Lavau-Denes S; Lacroix P; Maubon A; Preux PM; Genet D; Vénat-Bouvet L; Labourey JL; Martin J; Slaouti P; Tubiana-Mathieu N
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):65-73. PubMed ID: 23636449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients.
    Verso M; Agnelli G
    J Clin Oncol; 2003 Oct; 21(19):3665-75. PubMed ID: 14512399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis of catheter-related thrombosis in cancer patients.
    Prandoni P
    Lancet; 2009 Feb; 373(9663):523-4. PubMed ID: 19217973
    [No Abstract]   [Full Text] [Related]  

  • 9. Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial.
    Young AM; Billingham LJ; Begum G; Kerr DJ; Hughes AI; Rea DW; Shepherd S; Stanley A; Sweeney A; Wilde J; Wheatley K;
    Lancet; 2009 Feb; 373(9663):567-74. PubMed ID: 19217991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial.
    Karthaus M; Kretzschmar A; Kröning H; Biakhov M; Irwin D; Marschner N; Slabber C; Fountzilas G; Garin A; Abecasis NG; Baronius W; Steger GG; Südhoff T; Giorgetti C; Reichardt P
    Ann Oncol; 2006 Feb; 17(2):289-96. PubMed ID: 16317012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylaxis of catheter-related venous thrombosis in cancer patients.
    Karthaus M
    Support Care Cancer; 2008 Jul; 16(7):787-90. PubMed ID: 18274788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Venous thromboembolism associated with long-term use of central venous catheters in cancer patients].
    Debourdeau P; Chahmi DK; Zammit C; Farge-Bancel D
    Pathol Biol (Paris); 2008 Jun; 56(4):211-9. PubMed ID: 18395994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superior venocaval obstruction secondary to central venous catheter-related thromboses in two patients with metastatic colorectal carcinoma receiving weekly 5-flurouracil. Should adjusted-dose warfarin be used as thromboprophylaxis?
    Mainwaring CJ; Naylor E; Jerwood S; Hall V; Page A; James CM
    Blood Coagul Fibrinolysis; 2002 Dec; 13(8):749-53. PubMed ID: 12441915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboprophylaxis for catheter-related thrombosis in patients with cancer: a systematic review of the randomized, controlled trials.
    Carrier M; Tay J; Fergusson D; Wells PS
    J Thromb Haemost; 2007 Dec; 5(12):2552-4. PubMed ID: 18034768
    [No Abstract]   [Full Text] [Related]  

  • 15. Central line thrombosis in patients with cancer.
    Bona RD
    Curr Opin Pulm Med; 2003 Sep; 9(5):362-6. PubMed ID: 12904704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catheter-associated thrombosis: thromboprophylaxis or not?
    Levine M; Kakkar AK
    J Clin Oncol; 2005 Jun; 23(18):4006-8. PubMed ID: 15767646
    [No Abstract]   [Full Text] [Related]  

  • 17. Central venous catheter-related thrombosis and thromboprophylaxis in children: a systematic review and meta-analysis.
    Vidal E; Sharathkumar A; Glover J; Faustino EV
    J Thromb Haemost; 2014 Jul; 12(7):1096-109. PubMed ID: 24801495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dalteparin versus unfractionated heparin in critically ill patients.
    ; Cook D; Meade M; Guyatt G; Walter S; Heels-Ansdell D; Warkentin TE; Zytaruk N; Crowther M; Geerts W; Cooper DJ; Vallance S; Qushmaq I; Rocha M; Berwanger O; Vlahakis NE
    N Engl J Med; 2011 Apr; 364(14):1305-14. PubMed ID: 21417952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of low-dose warfarin as prophylaxis for central venous catheter thrombosis in patients with cancer: a meta-analysis.
    Rawson KM; Newburn-Cook CV
    Oncol Nurs Forum; 2007 Sep; 34(5):1037-43. PubMed ID: 17878131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer.
    Couban S; Goodyear M; Burnell M; Dolan S; Wasi P; Barnes D; Macleod D; Burton E; Andreou P; Anderson DR
    J Clin Oncol; 2005 Jun; 23(18):4063-9. PubMed ID: 15767639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.